Molecular Weight Markers Market By Product (DNA Markers, Protein Markers and RNA Markers), By Type (Unstained Markers, Prestained Markers and Specialty Markers), By Application (Nucleic Acid Applications and Proteomics Applications) - Growth, Future Prospects & Competitive Analysis, 2017 - 2025

Molecular weight markers are commonly known as DNA ladders, RNA ladders or protein ladders. The main function of the molecular weight markers is used for determination and identification of the molecular size of biological samples on gel electrophoresis by using the principle that molecular weight is inversely proportional to migration rate through a gel matrix. This method has undergone tremendous technological advancements and is now available in a wide range with loading buffer in a single tube, ready to use format which minimizes the time spent on thawing, diluting and adding the tracking dye to the DNA ladder.

For the purpose of this study, the various products studied are DNA markers, protein markers and RNA markers. DNA markers are further sub-segmented as (below 50 bp, 50 bp to 100 bp, 100 bp to 1 kb, 1 kb to 5 kb and above 5 kb). Protein markers are further classified as (below 10 kDa, 10 kDa to 100 kDa, 100 kDa to 200 kDa and above 200 kDa). The types of molecular weight markers considered in this study are unstained markers, prestained markers and specialty markers. The applications are categorized as nucleic acid applications and proteomics applications. Nucleic acid applications are further segmented as (PCR, Sequencing, Northern blotting, Southern blotting, molecular cloning and others). Proteomics applications are further classified as (Western blotting, gel extraction and others). Market size estimates and forecast of these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

The geographic segmentation of the global molecular weight markers market is performed for the regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa markets. The regions are also further sub-segmented on the basis of major countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of LATAM
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year. 

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global molecular weight markers market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global molecular weight markers market. The key players profiled in this report are Agilent Technologies, Bio-Rad Laboratories, Inc., F Hoffman La-Roche Ltd, Merck KGaA, New England Biolabs, Promega Corp., QIAGEN, Takara Bio, Inc. Thermo Fisher Scientific, Inc., VWR International, LLC and other notable players.

Molecular Weight Marker Market

Based on application, the global molecular weight markers market is categorized into

  • Nucleic Acid Applications
    • PCR
    • Sequencing
    • Northern Blotting
    • Southern Blotting
    • Molecular Cloning
    • Others
  • Proteomics Applications
    • Western Blotting
    • Gel Extraction
    • Others

Molecular Weight Marker Market

The molecular weight markers industry is witnessing tremendous growth significantly due to factors such as public-private partnership resulting in the expansion of research and development segment of pharmaceutical and biotechnology industries. Rare diseases diagnosis and treatment have been an eye catcher for the last decade leading to the incumbent demand for genome mapping to determine the biomarkers and targeted drug delivery to suppress the genetic factors responsible for the etiology of rare diseases.

In 2016, nucleic acid applications dominated the market. Factors such as increasing demand for the blotting techniques for the detection and transfer of DNA fragments onto a carrier allowing its use for gel electrophoresis drives this segment. Moreover, blotting techniques find huge application in gene discovery, DNA fingerprinting, diagnostics and forensics and the identification of transferred genes in transgenic individuals. The proteomics applications segment is anticipated to register faster growth throughout the forecast period 2017-2025, mainly attributed to rising prevalence of chronic diseases, increasing public health awareness resulting into early disease diagnosis and treatment. Proteomics study finds huge application in elucidating the additional components of biochemical pathways of microbes and analyze post-translational modification in the drug resistant bacteria.

For the purpose of this study, the global molecular weight markers market is categorized into the following regional and country specific markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Molecular Weight Marker Market

 

North America was observed to be the largest market for molecular weight marker in the base year 2016. The dominance of North America is mainly attributed to the presence of large research laboratories specializing in biotechnology research and existence of evolved research and healthcare institutions. The market growth in Europe is mainly attributed to the increasing number of patients suffering with chronic and rare diseases. This factor boosts the demand for the determination of the biomarkers aberrantly present in the chronic diseases such as diabetes, cancer, cardiovascular complications etc., which could be expressed and targeted for the treatment. Asia Pacific is estimated to be the fastest growing regional segment throughout the forecast period 2017-2025. Factors that are anticipated to propel the market growth are presence of large patient pool that can be enrolled in biopsy studies for the determination of disease etiology and to test the drug treatment regimen during clinical trials, competitive market due to presence of existing major players and evolving biopharmaceutical companies involved in the manufacturing of molecular weight markers in this region, and supportive regulatory environment for molecular weight marker products. Moreover, factors such as developing health infrastructure and establishment of research centers by major biopharmaceutical companies are going to fuel the rapid growth of molecular weight marker market in Latin America, and Middle East and Africa in the near future.   

Choose License Type
Published Date:  Oct 2017
Category:  Biotechnology
Report ID:   58750
Report Format:   PDF
Pages:   120
Rating:    4.2 (40)
Connect With Us
+1-408-641-3282
24/7 Research Support